You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A targeted drug for the treatment of inflammation in cystic fibrosis lung disease

    SBC: NANOMETICS LLC            Topic: NHLBI

    DESCRIPTION provided by applicant Problem to be Solved Cystic fibrosis CF is a global health issue that affects over people worldwide including Americans Lung disease is the primary cause of morbidity and mortality in CF patients and is characterized by intense inflammatory responses in the airways The Product and Long Term Goal Nanometics LLC dba PHD Biosciences PHD ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  2. A Therapeutic for Radiation Induced Lung Injury

    SBC: Angion Biomedica Corp.            Topic: NIAID

    DESCRIPTION (provided by applicant): Nuclear accidents and terrorism present a serious threat for causing mass-casualty scenarios. In radiation events, many people receive non-uniform whole-body or partial-body irradiation. The risk of exposure to ionizingradiation due to terrorist activities could result in acute injury as well as long-term adverse health effects in thousands of people. The lung ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. Automation of a Liver Genotoxicity Assay

    SBC: Litron Laboratories Ltd            Topic: NIEHS

    DESCRIPTION provided by applicant Assessment of chemicalsandapos potential to cause chromosomal damage is an established and important part of preclinical genotoxicity safety testing for many consumer products industrial chemicals and all pharmaceutical agents Currently the mammalian erythrocyte micronucleus test is the most commonly employed assay for in vivo assessment of chromosomal damage but ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  4. Babington Net-Power, Multi-liquid Fuel Heater/Cooker

    SBC: Babington Technology            Topic: 15NCER02

    For 50 years Babington has pioneered the field of ultra-clean combustion for home and off-grid heating and cooking. Our unique air-atomization and burner technology provides for near perfect combustion of liquid fuels with variable heat outputs. Babington burners have heated homes and millions of meals for U.S. militaries and disaster relief organizations worldwide. Recently, we reengineered ou ...

    SBIR Phase I 2016 Environmental Protection Agency
  5. Biomarker Matrix for Genotoxicity Mode of Action

    SBC: Litron Laboratories Ltd            Topic: NIEHS

    DESCRIPTION (provided by applicant): It is well recognized that current batteries of genetic toxicology assays exhibit relatively high sensitivity, meaning they effectively identify genotoxic carcinogens. However, a critical deficiency with current approaches exists-namely, the specificity of the in vitro mammalian cell genotoxicity tests is low, as they yield a high incidenc of positive results t ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Biosensor Assays for Diagnosis of Chronic HCV Infection

    SBC: ALDERON BIOSCIENCES, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): This Phase I SBIR application is submitted in response to the call by DHHS for new tests for qualitative measurement of HCV RNA for diagnosis of chronic HCV infection in patients. The need is for HCV RNA assays that areas reliable but less expensive and resource-demanding than current molecular assays. The new test proposed for research and development consists ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. BREATHE FREE: Smartphone Videogame-Based Incentives for Smoking Cessation

    SBC: ENTERTAINMENT SCIENCE PLAYMATICS, JV            Topic: NIDA

    DESCRIPTION (provided by applicant): Cigarette smoking remains the number one cause of preventable morbidity and mortality in the U.S. Each year, one third to one half of smokers attempt to quit at least once; however, approximately 94% of quit attempts fail. A number of interventions have been developed to help smokers initiate and maintain abstinence. Unfortunately, even though most smokers expr ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Building a Low Cost High Density Data Gathering Platform For Studying High-functioning Elders

    SBC: Human Project Inc.            Topic: NIA

    By the time an individual is diagnosed with Alzheimer s Disease AD or dementia they have often already experienced both gradual and dramatic changes to their health cognitive function employment and financial status among other life events A number of key interview based studies like The National Health and Aging Trends Study NHATS and The Health and Retirement Study HRS have provided u ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  9. Casein Kinase 1 Inhibitors for Treatment of Autism

    SBC: INTRA-CELLULAR THERAPIES, INC.            Topic: NIMH

    PAR-11-133 - PI, Gretchen L. Snyder, PhD Casein Kinase I Inhibitors for Autism Project Summary/Abstract Autism is a neurodevelopmental disorder characterized by abnormal social interaction, deficits in interpersonal communication, and repetitive stereotyped behaviors with a number of individually- occurring associated symptoms, including intellectual impairment, anxiety, seizures, hyperactivity, h ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Cell analysis and immunoassay device for distributed HIV diagnosis and monitoring

    SBC: INDEXUS BIOMEDICAL, LLC            Topic: NIAID

    DESCRIPTION (provided by applicant): The goal of this research is to develop a new approach to bring diagnosis and monitoring tests for HIV to the primary care level (primary care provider office, small healthcare clinics and labs, and community health center labs) by introducing a multi-functional cell analysis and immunoassay platform that is portable, low cost and easy to use. It will allow pat ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government